Posttraumatic Stress Disorder (PTSD): Symptoms, Diagnosis, and Treatment
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Posttraumatic stress disorder (PTSD) is a diagnosable trauma-related mental health condition that can develop after exposure to actual or threatened death, serious injury, or sexual violence. It involves a persistent pattern of trauma-related re-experiencing, avoidance, changes in mood and thinking, and heightened threat responses that cause significant distress or interfere with life. Some people have nightmares and vivid flashbacks; others experience emotional numbness, distrust, guilt, poor sleep, or persistent hypervigilance. The symptoms and severity differ across individuals. The World Health Organization's September 2026 overview makes clear that most people exposed to potentially traumatic events do not develop PTSD.
This guide explains symptoms, the distinct DSM-5-TR and ICD-11 diagnostic frameworks, assessment and differential diagnosis, treatments with the strongest research support, medications, age-related considerations, and recovery. Its principal clinical references are the 2023 VA/DoD PTSD guideline, the American Psychological Association's 2025 PTSD guideline, and NICE guideline NG116. It is educational information to support informed clinical decisions, not a method of diagnosing an individual from symptoms alone.
For an overview of evidence-based PTSD care, see Psychological Trauma: Meaning, Responses, and Recovery.
What Is PTSD?
PTSD is a clinical disorder defined by both the context of traumatic exposure and a recognizable combination of symptoms that persist and impair functioning. Under the American Psychiatric Association's DSM-5-TR, PTSD belongs to trauma- and stressor-related disorders. The World Health Organization's ICD-11 places PTSD among disorders specifically associated with stress. The diagnostic systems overlap but use different symptom arrangements. A professional evaluation is required to establish which criteria, if any, are met.
A person can experience severe distress after an adverse event without meeting PTSD criteria, and even a qualifying event does not inevitably result in PTSD. In clinical care, the purpose of the diagnosis is to identify the pattern accurately and guide treatment. The VA's DSM-5-TR explanatory resource describes exposure, symptom clusters, duration and impairment.
What Events Can Lead to PTSD?
DSM-5-TR describes exposure to actual or threatened death, serious injury, or sexual violence through direct experience, witnessing the event in person, learning that it happened to a close family member or friend under defined circumstances, or repeated or extreme exposure to aversive details as part of work. Ordinary exposure through news or social media generally does not satisfy the occupational exposure route. The relevant circumstances require careful assessment.
Potential exposures include sexual assault, combat, severe interpersonal violence, a serious accident, disaster, and certain life-threatening medical events. Multiple traumatic experiences may increase complexity, yet repeated exposure is not required. Exposure characteristics, symptoms, impairment and their relationship in time must be evaluated together. The NIH clinical overview lists a range of contexts in which PTSD can arise.
In everyday language, trauma also describes grief, humiliation, bullying, abandonment, betrayal, or other deeply distressing events. These experiences can have important mental health consequences. Their colloquial description as traumatic does not itself establish the narrower DSM-5-TR traumatic exposure criterion. A respectful clinical assessment considers the reality of the distress and the correct diagnosis separately.
PTSD Symptoms: The Four DSM-5-TR Groups
DSM-5-TR organizes the adult PTSD symptom pattern into four groups: intrusion, avoidance, negative changes in cognition and mood, and altered arousal and reactivity. The person must meet a combination of symptom thresholds across the groups, together with duration, exposure, impairment and exclusion criteria. A single nightmare, panic attack or episode of numbness is not enough to determine a PTSD diagnosis.
Intrusive Memories, Nightmares and Flashbacks
Intrusion symptoms can include involuntary distressing memories, recurrent trauma-related dreams, dissociative reactions such as flashbacks, and intense emotional or bodily distress when confronted with reminders. During a flashback, the event may feel as if it is happening again; the experience varies in intensity. A distressing memory is not necessarily a flashback, and not every nightmare about danger is trauma-related.
Intrusions often occur in response to sights, sounds, smells, dates or situations that resemble an aspect of the event, though a clear trigger is not always recognized. A clinician explores their character and relationship to the exposure, rather than inferring their significance from frequency alone.
Avoidance of Memories and Reminders
Avoidance involves efforts to stay away from internal experiences, external reminders, or both. A survivor might stop traveling along a particular road, avoid conversations, suppress memories, or withdraw from activities associated with the event. Such behaviors may offer short-term relief yet narrow daily life and help maintain a sense of danger.
Avoiding an unsafe environment can be protective. Clinicians distinguish realistic present danger from avoidance of safe reminders before planning a treatment that involves approaching avoided situations.
Negative Thoughts, Mood and Emotional Connection
Some people develop exaggerated beliefs that the world is wholly unsafe, blame themselves for the event, experience persistent shame, anger or guilt, lose interest in valued activities, feel detached from others, or find it difficult to experience positive emotions. In some cases, they cannot recall important parts of the event. Problems remembering details should not be taken as proof of a particular hidden memory.
These symptoms overlap with depression, complicated grief, and other conditions. Their timing, relationship to the event and combination with intrusion and avoidance inform the assessment.
Hyperarousal, Startle, Sleep and Concentration
Heightened arousal can involve hypervigilance, an exaggerated startle reaction, irritability, angry outbursts, sleep disruption, difficulty concentrating or self-destructive behavior. Someone may continually scan exits or awaken frequently without feeling rested. The VA diagnostic guide summarizes the DSM-5-TR cluster structure.
No single bodily sensation, brain scan, heart-rate pattern, sleep measurement or symptom checklist establishes PTSD. A clinician interprets physical experiences alongside the whole diagnostic picture and assesses medical explanations when appropriate.
PTSD, Acute Stress Reaction and Acute Stress Disorder
Early distress after a traumatic event may include fear, numbness, confusion, intrusive memories, trouble sleeping and heightened vigilance. Many people improve naturally over the following weeks. Acute stress reaction is a descriptive term for immediate responses and need not mean a sustained psychiatric disorder.
Acute stress disorder (ASD) is a specific DSM diagnosis involving clinically significant trauma-related symptoms lasting from three days to one month after exposure. PTSD under DSM-5-TR requires a duration longer than one month. Not everyone with ASD later develops PTSD, and PTSD can develop without a prior ASD diagnosis. Symptoms can become fully evident later; a delayed presentation does not eliminate the need for a careful diagnostic assessment. The VA/DoD guideline addresses assessment during both the immediate and later phases.
PTSD trajectories vary substantially. Some people recover within months, others experience persisting difficulties, and symptoms may intensify around reminders or renewed threats. The WHO population-level summary should not be used to predict any particular person's recovery timeline.
How Is PTSD Diagnosed?
A qualified clinician reviews the exposure, onset, duration, all relevant symptoms, associated distress and functioning, medical history, other mental health conditions, substance use, medications and current safety. The assessment may include structured interviews and self-report measures. A sound diagnosis requires distinguishing qualifying exposure from general stress and distinguishing characteristic PTSD symptoms from look-alike problems.
DSM-5-TR Criteria
The adult DSM-5-TR framework includes at least one intrusion symptom, one avoidance symptom, two negative cognition or mood symptoms, and two arousal or reactivity symptoms. These occur following qualifying exposure, last longer than one month, cause clinically significant distress or impairment, and cannot be attributed to substances or another medical condition. Developmentally adapted criteria apply to children aged six or younger. See the VA summary of DSM-5-TR PTSD.
DSM-5-TR also includes a dissociative subtype for people who satisfy the PTSD criteria and have prominent depersonalization or derealization. Feeling disconnected from oneself or experiencing the environment as unreal warrants careful assessment. This PTSD specifier is distinct from making a separate diagnosis of a dissociative disorder.
ICD-11 PTSD and Complex PTSD
ICD-11 places greater emphasis on three core dimensions of PTSD: re-experiencing the event as occurring in the present, avoiding reminders, and a continuing sense of current threat, with associated impairment. Its separate complex PTSD (CPTSD) category additionally involves persistent disturbances in emotion regulation, negative self-concept and relationships. Under ICD-11, PTSD and CPTSD are alternative diagnostic categories.
DSM-5-TR does not designate CPTSD as an independent diagnosis. ICD-11 CPTSD does not require a specific type or length of trauma; repeated interpersonal trauma is an important risk context, not a mandatory defining exposure. The VA's 2026 review of complex PTSD definitions and complex PTSD assessment guidance explain the clinical and research distinctions.
Screening: PC-PTSD-5, PCL-5 and CAPS-5
The brief PC-PTSD-5 is used for screening in appropriate health care settings. The PTSD Checklist for DSM-5 (PCL-5) records self-reported symptoms and can track change over treatment. Neither instrument establishes diagnosis on its own. Cutoff scores vary by population, use and setting, so a single internet score should not be presented as a definitive diagnosis.
The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) provides a structured clinical interview. The 2023 VA/DoD guideline synopsis suggests validated clinician-administered assessment for diagnostic confirmation and validated tools for monitoring. The VA CAPS-5 resource describes its administration; the VA PCL-5 resource describes self-reported symptom measurement. ICD-11 PTSD and CPTSD require measures and interviews appropriate to that system, such as the International Trauma Questionnaire, with the same principle of clinical interpretation.
Why Does PTSD Develop in Some People and Not Others?
PTSD risk reflects interacting aspects of the event, previous experiences, ongoing stress, available support, personal history and context. Perceived threat, injury, repeated danger, social adversity and co-occurring problems can all influence the course, but no single factor predicts every outcome. The WHO overview emphasizes that most people experiencing potentially traumatic events do not develop PTSD.
Psychological models examine how reminders become associated with threat, how avoidance sustains fear, and how interpretations of responsibility, danger and trust affect reactions. Trauma-focused therapies work with these mechanisms in structured ways. Research into stress physiology and brain networks also contributes to understanding PTSD, but it has not established an individual-level biological diagnostic test for routine care.
Supportive relationships, practical security and access to care matter. Their associations with symptom reduction should be interpreted carefully, because observational research does not always establish how much improvement is caused by any single support factor.
Differential Diagnosis and Co-Occurring Conditions
PTSD may coexist with depression, anxiety disorders, OCD, substance use disorders, insomnia, chronic pain and other mental or physical conditions. Traumatic brain injury, neurological symptoms, medication effects and acute intoxication or withdrawal can complicate concentration, memory or arousal. Clinicians evaluate each possible explanation rather than attributing every new problem to an earlier trauma.
Generalized anxiety disorder is chiefly associated with pervasive worry about different life domains, whereas PTSD includes a qualifying exposure and characteristic trauma-related symptoms. The English Hub maintains a separate anxiety versus PTSD comparison. Obsessions and compulsions in OCD can resemble intrusive memories and avoidance, but their clinical mechanisms and diagnostic criteria differ; the OCD versus PTSD article covers that distinction in depth.
Depression can share detachment, negative thinking and sleep problems. Prolonged grief disorder is organized around a persistent grief response following bereavement. Adjustment disorder can follow significant stressors without necessarily satisfying the qualifying exposure criterion for PTSD. Dissociative symptoms may be part of PTSD or merit separate assessment. Differential diagnosis is based on the whole course and context, not one popular label.
PTSD in Children and Adolescents
Children may communicate trauma-related distress through play, changes in behavior, frightening dreams, irritability, loss of previously acquired skills, school difficulties or avoidance. Developmental stage shapes both symptoms and their expression. Clinical assessment may involve parents or caregivers, with attention to the child's safety and circumstances.
The NICE guideline recommends age-adapted trauma-focused CBT for appropriate children and young people experiencing PTSD or clinically important symptoms, with different recommendations depending on age and timing. It does not recommend drug treatment to prevent or treat PTSD in people under 18 as routine PTSD care. Childhood-specific exposures, ACEs and longer-term effects have a separate canonical owner in the English Hub: Childhood Trauma and PTSD.
Evidence-Based Psychotherapy for Adult PTSD
Structured trauma-focused psychological treatments have the strongest consistent support in major adult clinical guidelines. The VA/DoD 2023 guideline prioritizes specified manualized psychotherapies over medication where appropriate. The APA 2025 guideline and NICE recommendations also support trauma-focused interventions while differing in the exact wording and strength of particular recommendations.
A clinician and patient should decide together which approach fits the diagnosis, preferences, available expertise, prior experiences, comorbidities and safety needs. PTSD treatment is a defined clinical intervention. A broad marketing label such as trauma-informed or somatic does not establish equivalent evidence of effectiveness.
Cognitive Processing Therapy (CPT)
CPT is a structured cognitive treatment addressing rigid, distress-maintaining beliefs following trauma. It helps people reconsider meanings related to safety, guilt, responsibility, trust, control, esteem and intimacy, and supports changes in functioning. It is one of the major first-line psychotherapies for PTSD and differs in structure from prolonged exposure.
A randomized clinical trial in 916 US veterans found meaningful symptom improvements with both CPT and prolonged exposure. Prolonged exposure had a statistical advantage that did not meet the study's prespecified threshold for clinical significance. The findings support shared decisions, while the particular veteran population limits direct generalization to everyone.
Prolonged Exposure (PE)
PE is a structured treatment that helps patients approach trauma memories and objectively safe situations previously avoided because of fear. Clinicians plan and monitor the work collaboratively and assess present safety. The approach addresses threat expectations and avoidance through carefully organized therapeutic experiences.
The evidence for PE is strong in adults, but that does not justify instructions to undertake intense exposure independently, recreate danger or forcibly retrieve distressing memories. Treatment requires trained professional oversight and attention to clinical circumstances. The VA/DoD guideline describes its place in care.
Trauma-Focused CBT and Cognitive Therapy
Trauma-focused cognitive behavioral therapy refers to structured treatments specifically addressing memories, interpretations and behaviors linked to trauma. Cognitive therapy for PTSD and narrative exposure therapy are among approaches discussed by guidelines, although protocols, evidence and recommendations vary. General supportive conversations or generic stress-management CBT should not be represented as identical to a validated trauma-focused protocol.
Therapy may include education, work with guilt or shame, changes in avoidance and restoration of social or occupational activity. The NICE guideline outlines components, typical treatment duration and when additional sessions may be needed.
Eye Movement Desensitization and Reprocessing (EMDR)
EMDR is a structured psychotherapy in which focused attention to distressing memories is accompanied by bilateral stimulation, commonly eye movements. Treatment also involves preparation, assessment, processing and reevaluation. Its effectiveness concerns the complete protocol. Researchers continue to study the contribution of individual elements and its mechanisms.
EMDR is among the PTSD therapies recommended by VA/DoD and recognized by NICE for specified circumstances. A self-directed video imitating eye movements is not equivalent to the clinically studied intervention.
Complex PTSD and Additional Clinical Needs
People with complex PTSD presentations or co-occurring depression, dissociation, substance use problems or relationship difficulties may need treatment adaptation and additional support. Skills-based programs and phased approaches have some evidence, but a mandatory stabilization phase before all trauma-focused work has not been established for everyone. The VA complex PTSD treatment review explains the current evidence and limits.
Medications for PTSD
Medication can be considered when psychotherapy is unavailable, declined or insufficient, and where symptoms or co-occurring conditions make prescribing appropriate. The VA medication evidence guide identifies sertraline, paroxetine and venlafaxine as pharmacological options with evidence for adult PTSD. Sertraline and paroxetine carry US FDA approval for PTSD; venlafaxine has a different labeling status. Medication decisions include medical history, interactions, possible adverse effects, pregnancy-related considerations and monitoring.
Prazosin has a narrower evidence-supported role for PTSD-associated nightmares in VA/DoD recommendations, rather than for overall PTSD symptom remission. The guideline recommends against benzodiazepines and cannabis or cannabis derivatives for treating PTSD. Evidence does not justify presenting unregulated supplements, psychedelics or ketamine as established routine PTSD treatments. Prescribed medications should be reviewed with a clinician, and discontinuation may require a gradual plan.
Combined psychotherapy and medication may be reasonable for individual circumstances, yet it should not be claimed that combining them always outperforms appropriate monotherapy. Shared planning and measurement of benefit and adverse effects are essential.
Online Therapy, Digital Interventions and AI Chatbots
Secure clinician-delivered teletherapy can make evidence-based PTSD treatment more accessible. The VA/DoD clinical practice guideline synopsis endorses appropriate secure video delivery of validated PTSD psychotherapy. Suitability depends on privacy, treatment protocol, technical access, safety and the ability to manage crises.
Clinician-guided teletherapy, therapist-supported computerized CBT, self-help tools, experimental digital therapies and general-purpose chatbots are different intervention categories. Evidence for one category should not be attributed to another. NICE considers supported computerized trauma-focused CBT for selected adults while specifying restrictions for severe dissociation and safety risk. An AI companion should not be presented as clinically validated PTSD therapy without direct evidence for that specific purpose.
What Helps Immediately After Trauma?
Early care centers on immediate safety, needed medical support, clear information, practical assistance, and social connection when wanted. Reactions can be monitored and follow-up arranged if they persist or worsen. Trauma-focused care may be offered to adults with acute stress disorder or clinically important PTSD symptoms within the first month, in accordance with the relevant guideline. There is no single procedure indicated for every survivor.
Routine compulsory psychologically focused debriefing, in which everyone is required to recount the experience immediately, is not recommended for PTSD prevention. NICE NG116 explicitly advises against this intervention. Early trauma-focused treatment for clinically significant symptoms is a distinct, appropriately assessed clinical action.
Recovery: What Improvement Can Look Like
Recovery may involve fewer nightmares, reduced avoidance, better concentration and sleep, less constant alertness, stronger relationships, or renewed participation in daily activities. Some people no longer meet diagnostic criteria after effective treatment; others improve markedly while continuing to manage symptoms. Symptoms can fluctuate with reminders, renewed threats and periods of stress. No universal recovery timetable applies.
Stages of trauma recovery can be a helpful model in some therapeutic traditions but are not required clinical phases for every person. Movement, sleep routines, manageable physical activity, trusted relationships and practical support can contribute to well-being. Grounding techniques may help in moments of intense distress, but do not replace evidence-based care for significant PTSD. Ongoing violence, serious instability and suicidal risk call for tailored professional and safety intervention.
Expressions such as emotional flashbacks and moral injury describe experiences or research constructs rather than separate DSM-5-TR PTSD diagnoses. Trauma stored in the body can serve as a metaphor for physical stress reactions, while literal claims that particular muscles store trauma memories or that body exercises reliably release them require stronger evidence. Physical symptoms deserve appropriate medical assessment when indicated.
Finding Appropriate Care and Staying Safe
A qualified clinician experienced in PTSD can explain the diagnostic approach, screen for co-occurring difficulties, and discuss options such as CPT, PE, EMDR or another guideline-supported treatment. Useful questions include how treatment progress is monitored, the clinician's training in the selected protocol, potential burdens, crisis procedures and when the plan might be adjusted.
People exposed to ongoing violence need safety planning and appropriate protective or community services alongside mental health care. If there is imminent danger of self-harm, harm to others or an acute medical emergency, contact local emergency services or a crisis service immediately. In the United States, 988 is available for suicide and mental health crisis support.
Frequently Asked Questions
What are the earliest signs of PTSD?
Intrusive recollections, nightmares, sleep problems, avoidance, heightened startle, irritability or detachment may appear early. Some are common short-term reactions after trauma. PTSD requires a more specific clinical pattern and duration.
Can PTSD occur without flashbacks?
Yes. Intrusion symptoms can include unwanted memories, nightmares or intense emotional and physical reactions to reminders. Flashbacks are one possibility among several.
Can PTSD appear months or years later?
Yes. Symptoms may increase over time or reach the full threshold later. DSM-5-TR describes delayed expression when full criteria are not met until at least six months after exposure, even though some symptoms may have appeared earlier.
Does everyone who experiences trauma develop PTSD?
No. Most do not, even though distress following trauma is common. Risk varies with the event, personal circumstances and aftermath. The WHO overview describes population-level patterns.
Are PTSD and complex PTSD the same diagnosis?
Under ICD-11 they are distinct alternatives, with complex PTSD adding persistent difficulties in emotion regulation, self-concept and relationships. DSM-5-TR does not recognize CPTSD as a separate diagnosis. See the VA definition review.
Does a high PCL-5 score prove PTSD?
No. Screening scores indicate symptom burden and the possible need for assessment. A clinician must evaluate traumatic exposure, the full symptom pattern, timing, impairment and alternative explanations.
Which psychotherapy is most effective?
CPT, PE and EMDR have substantial evidence for adult PTSD. Differences between studies and the person's circumstances make informed treatment choice more useful than claiming a universally best option.
Are medications helpful?
Some antidepressants, especially sertraline, paroxetine and venlafaxine, have evidence for PTSD symptom reduction in adults. Their suitability and risks must be considered by a prescriber.
Can PTSD resolve completely?
Yes, some people recover enough to no longer meet the diagnosis. Others achieve substantial improvements with residual symptoms. Recovery varies and cannot be promised on a fixed schedule.
Is PTSD limited to combat veterans?
No. Qualifying exposure can involve sexual assault, accidents, disasters, violence and other potentially life-threatening circumstances.
What if I think I have PTSD?
Seek a qualified assessment if symptoms persist, interfere with life or raise safety concerns. If a threat is ongoing, prioritize safety. A questionnaire or internet label is a starting point for questions, not a substitute for evaluation.
Related Articles
References
American Psychological Association. (2025). Clinical practice guideline for the treatment of posttraumatic stress disorder in adults. Official guideline.
National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder: NICE guideline NG116. Recommendations.
National Institutes of Health. (2026). Post-traumatic stress disorder. NIH overview.
Schnurr, P. P., Chard, K. M., Ruzek, J. I., et al. (2022). Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans. JAMA Network Open, 5(1), e2136921. DOI.
Schnurr, P. P., Hamblen, J. L., Wolf, J., et al. (2024). The management of posttraumatic stress disorder and acute stress disorder: Synopsis of the 2023 VA/DoD clinical practice guideline. Annals of Internal Medicine, 177(3). DOI.
U.S. Department of Veterans Affairs, National Center for PTSD. (2026). Complex PTSD: History and definitions. Clinical overview.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). Clinician's guide to medications for PTSD. Medication evidence.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). Clinician-administered PTSD scale for DSM-5. CAPS-5.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). PTSD and DSM-5. Diagnostic summary.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). PTSD checklist for DSM-5. PCL-5.
U.S. Department of Veterans Affairs and U.S. Department of Defense. (2023). Clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder. VA/DoD guideline.
World Health Organization. (2026, September 11). Post-traumatic stress disorder. WHO fact sheet.